International Pharmaceutical Supply Chain Security Agreement Act of 2021
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Jul 27, 2021)
International Pharmaceutical Supply Chain Security Agreement Act of 2021
This bill establishes principal trade negotiating objectives of the United States with respect to pharmaceutical products, including objectives regarding subsidies and government procurement. It also extends through July 1, 2023 (or July 1, 2026, if the President receives an extension) the authority of the President to enter into trade agreements with foreign countries.
What just happenedJul 27, 2021
Referred to the Subcommittee on Trade.
Who’s behind it
- Introduced in HouseJul 27, 2021
- Jul 27, 2021Committee
Referred to the Subcommittee on Trade.
Trade Subcommittee - Jul 27, 2021IntroReferralH11100
Referred to the Committee on Ways and Means, and in addition to the Committee on Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Rules Committee - Jul 27, 2021IntroReferralH11100
Referred to the Committee on Ways and Means, and in addition to the Committee on Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Jul 27, 2021IntroReferralIntro-H
Introduced in House
- Jul 27, 2021IntroReferral1000
Introduced in House